Hosted on MSN
Zeiss’ AI-driven tool gets CE mark for OCT scans
Zeiss Medical Technology has received CE mark approval for its CIRRUS PathFinder, a clinical support tool that utilises AI to assist in the interpretation of optical coherence tomography (OCT) scans.
ANAHEIM, California — Optical coherence tomography (OCT) angiography can reveal the microaneurysms that are the first signs of diabetic retinopathy, new research shows. If these microaneurysms are ...
An “optical biopsy” of intravascular plaque during stenting is more effective at reducing the rate of restenosis or thrombosis in people with moderately or severely calcified lesions than angiography ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback